Hodgkin's lymphoma market size is expected to increase during the forecast period (2025–2034) owing to increasing incidence, advancements in ...

A novel prediction model estimated 2-year PFS for adults with early-stage classic Hodgkin lymphoma based on four “readily ...

Marginal zone lymphoma is a group of rare blood cancers that start in your lymphatic system. This system elps your body fight infections. Many treatments can help because MZL is so slow-growing.

Young patients with advanced Hodgkin's lymphoma, a cancer of the lymphatic system, now have a better chance of having their own children after treatment. An international study led by the German ...

Polivy is used to treat a type of non-Hodgkin's lymphoma called diffuse large B-cell lymphoma (DLBCL). Below you'll find common questions and answers about Polivy to help decide whether it's right ...

A prognostication tool for early classic Hodgkin's lymphoma outperformed a widely used risk-classification system for predicting 2-year progression-free survival. The model uses four variables ...

A response-adapted approach to the treatment of patients with advanced Hodgkin's lymphoma de-escalates treatment after an early negative PET scan and intensifies treatment in those with a PET ...

olivia hodgkin’s lymphoma survivor, reconnected with the team who helped her through her treatment. OLIVIA WAS DIAGNOSED WITH STAGE FOUR HODGKIN’S LYMPHOMA IN 2023. SHE HAD TO UNDERGO ...

Non-Hodgkin’s lymphoma (NHL): This is the most common type in people with HIV, and doctors consider it a stage 3 HIV-defining illness. Hodgkin’s lymphoma: This type accounts for approximately ...

For European Week Against Cancer, clinical pharmacist Hassan Thwaini writes about his Hodgkin’s lymphoma diagnosis at the age of 14: “I thought feeling tired was just part of being a teenager ...